Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y. Jamin
The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Related publications
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
The Long Non-Coding RNA MYCNOS-01 Regulates MYCN Protein Levels and Affects Growth of MYCN-amplified Rhabdomyosarcoma and Neuroblastoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Epigenetic Regulation of the Neuroblastoma Genes, Arid3b and Mycn
Oncogene
Cancer Research
Genetics
Molecular Biology
ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma
Frontiers in Oncology
Cancer Research
Oncology
Burkholderia Lethal Factor 1, a Novel Anti-Cancer Toxin, Demonstrates Selective Cytotoxicity in MYCN-Amplified Neuroblastoma Cells
Toxins
Mutagenesis
Toxicology
Health
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Cancer Cell
Cancer Research
Oncology
Cell Biology
P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
